Inventor · disambiguated record
Sandeep Dutta
Also filed as: DUTTA SANDEEP
18 granted patents·35 pending applications·264 citations·filing 2000–2025
95Inventor score
Top patents by PatentIndex Score
53 records- 0195US8993578B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Mar 31, 2015·15 cites·2 claims
- 0295US8969357B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Mar 3, 2015·14 cites·2 claims
- 0395US8685984B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Apr 1, 2014·19 cites·20 claims
- 0495US8680106B2Methods for treating HCVABBVIE INC·Filed 2013·Granted Mar 25, 2014·16 cites·20 claims
- 0595US8492386B2Methods for treating HCVBERNSTEIN BARRY M·Filed 2012·Granted Jul 23, 2013·28 cites·16 claims
- 0695US8466159B2Methods for treating HCVBERNSTEIN BARRY M·Filed 2012·Granted Jun 18, 2013·33 cites·16 claims
- 0792US8809265B2Methods for treating HCVABBVIE INC·Filed 2012·Granted Aug 19, 2014·21 cites·11 claims
- 0890US6713086B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2002·Granted Mar 30, 2004·43 cites·17 claims
- 0989US8853176B2Methods for treating HCVABBVIE INC·Filed 2012·Granted Oct 7, 2014·12 cites·3 claims
- 1086US10286029B2Method for treating HCVABBVIE INC·Filed 2015·Granted May 14, 2019·7 cites·34 claims
- 1185US8435523B2Antibodies against nerve growth factor (NGF) with enhanced in vivo stabilityPOWELL JOHN·Filed 2010·Granted May 7, 2013·17 cites·9 claims
- 1283US6528090B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2000·Granted Mar 4, 2003·18 cites·7 claims
- 1380US6720004B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2002·Granted Apr 13, 2004·10 cites·3 claims
- 1480US6511678B2Controlled release formulation of divalproex sodiumABBOTT LAB·Filed 2000·Granted Jan 28, 2003·10 cites·8 claims
- 1577US11484534B2Methods for treating HCVABBVIE INC·Filed 2017·Granted Nov 1, 2022·1 cites·23 claims
- 1671US2024232171A1Methods for Treating HCVABBVIE INC·Filed 2024·Application pending·0 cites
- 1769US2009022798A1Formulations of nonopioid and confined opioid analgesicsABBOTT GMBH & CO KG·Filed 2007·Application pending·0 cites
- 1868US2025057837A1Methods for Treating HCVABBVIE INC·Filed 2024·Application pending·0 cites
- 1965US2024115650A1Methods for Treating HCVABBVIE INC·Filed 2023·Application pending·0 cites
- 2065US2025375452A1Sotorasib dosing regimenAMGEN INC·Filed 2025·Application pending·0 cites
- 2164US2013344143A1Formulations of nonopioid and confined opioid analgesicsABBVIE DEUTSCHLAND·Filed 2012·Application pending·0 cites
- 2262US2004156897A1Controlled release formulation of divalproex sodiumFiled 2004·Application pending·0 cites
- 2362US2004156898A1Controlled release formulation of divalproex sodiumFiled 2004·Application pending·0 cites
- 2460US2015164976A1Methods for Treating HCVABBVIE INC·Filed 2015·Application pending·0 cites
- 2560US2015196615A1Methods for Treating HCVABBVIE INC·Filed 2015·Application pending·0 cites
- 2659US9452194B2Methods for treating HCVABBVIE INC·Filed 2014·Granted Sep 27, 2016·0 cites·9 claims
- 2759US2010172989A1Abuse resistant melt extruded formulation having reduced alcohol interactionABBOTT LAB·Filed 2009·Application pending·0 cites
- 2859US2024261289A1Sotorasib dosing regimenAMGEN INC·Filed 2022·Application pending·0 cites
- 2958US2011229526A1Formulations of nonopioid and confined opioid analgesicsROSENBERG JOERG·Filed 2011·Application pending·0 cites
- 3055US2022288153A1Methods for Treating HCVABBVIE INC·Filed 2021·Application pending·0 cites
- 3153US2017014348A1Formulations of Nonopioid and Confined Opioid AnalgesicsABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3253US2018177779A1Methods for Treating HCVABBVIE INC·Filed 2016·Application pending·0 cites
- 3353US2023385268A1Methods for Treating HCVABBVIE INC·Filed 2023·Application pending·0 cites
- 3452US2015011481A1Methods for Treating HCVABBVIE INC·Filed 2014·Application pending·0 cites
- 3552US2016237491A1Methods for treating hcvABBVIE INC·Filed 2014·Application pending·0 cites
- 3652US2014323395A1Methods for Treating HCVABBVIE INC·Filed 2014·Application pending·0 cites
- 3751US2019336565A1Methods for Treating HCVABBVIE INC·Filed 2019·Application pending·0 cites
- 3851US2025127782A1Methods of treating cancerAMGEN INC·Filed 2022·Application pending·0 cites
- 3950US2016228496A1Methods for treating hcvABBVIE INC·Filed 2014·Application pending·0 cites
- 4049US2022323446A1Sotorasib dosing regimenAMGEN INC·Filed 2022·Application pending·0 cites
- 4145US2018042982A1Methods for Treating HCVABBVIE INC·Filed 2017·Application pending·0 cites
- 4244US9447181B2Antibodies against nerve growth factor (NGF) with enhanced in vivo stabilityABBVIE RES B V·Filed 2013·Granted Sep 20, 2016·0 cites·3 claims
- 4343US2014275099A1Methods for treating hcvABBVIE INC·Filed 2014·Application pending·0 cites
- 4443US2014274934A1Methods for treating hcvABBVIE INC·Filed 2014·Application pending·0 cites
- 4541US2018085330A1Dose AdjustmentABBVIE INC·Filed 2017·Application pending·0 cites
- 4641US2018177778A1Methods for Treating HCVABBVIE INC·Filed 2016·Application pending·0 cites
- 4739US2015209403A1Dose AdjustmentABBVIE INC·Filed 2015·Application pending·0 cites
- 4838US8222278B2Treatment of attention-deficit/hyperactivity disorderBAIN EARLE E·Filed 2009·Granted Jul 17, 2012·0 cites·3 claims
- 4938US2002031549A1Controlled release formulation of divalproex sodiumFiled 2001·Application pending·0 cites
- 5038US2002025341A1Controlled release formulation of divalproex sodiumFiled 2001·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sandeep Dutta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →